PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Runx1
|
ENSMUSG00000022952.18 | Runx1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Runx1 | mm39_v1_chr16_-_92622972_92623037 | 0.85 | 8.9e-21 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr15_+_80456775 | 32.06 |
ENSMUST00000229980.2
|
Grap2
|
GRB2-related adaptor protein 2 |
chr3_-_59009231 | 26.07 |
ENSMUST00000085040.5
|
Gpr171
|
G protein-coupled receptor 171 |
chr2_-_58050494 | 19.90 |
ENSMUST00000028175.7
|
Cytip
|
cytohesin 1 interacting protein |
chr3_+_103767581 | 19.51 |
ENSMUST00000029433.9
|
Ptpn22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
chr16_-_92622972 | 18.91 |
ENSMUST00000023673.14
|
Runx1
|
runt related transcription factor 1 |
chr11_-_69786324 | 18.44 |
ENSMUST00000001631.7
|
Acap1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr13_-_113237505 | 18.05 |
ENSMUST00000224282.2
ENSMUST00000023897.7 |
Gzma
|
granzyme A |
chr15_-_66673425 | 16.60 |
ENSMUST00000168589.8
|
Sla
|
src-like adaptor |
chr1_-_138102972 | 16.31 |
ENSMUST00000195533.6
ENSMUST00000183301.8 |
Ptprc
|
protein tyrosine phosphatase, receptor type, C |
chr1_+_60785517 | 16.28 |
ENSMUST00000027165.3
|
Cd28
|
CD28 antigen |
chr1_-_138103021 | 16.20 |
ENSMUST00000182755.8
ENSMUST00000193650.2 ENSMUST00000182283.8 |
Ptprc
|
protein tyrosine phosphatase, receptor type, C |
chr14_-_122153185 | 14.74 |
ENSMUST00000055475.9
|
Gpr18
|
G protein-coupled receptor 18 |
chr15_-_78377926 | 14.26 |
ENSMUST00000163494.3
|
Il2rb
|
interleukin 2 receptor, beta chain |
chrX_-_7956682 | 14.00 |
ENSMUST00000033505.7
|
Was
|
Wiskott-Aldrich syndrome |
chr11_-_46280298 | 13.58 |
ENSMUST00000109237.9
|
Itk
|
IL2 inducible T cell kinase |
chrX_-_56384089 | 13.38 |
ENSMUST00000033468.11
|
Arhgef6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
chr11_-_52173391 | 13.08 |
ENSMUST00000086844.10
|
Tcf7
|
transcription factor 7, T cell specific |
chr7_+_44221791 | 13.07 |
ENSMUST00000002274.10
|
Napsa
|
napsin A aspartic peptidase |
chr11_-_46280336 | 12.86 |
ENSMUST00000020664.13
|
Itk
|
IL2 inducible T cell kinase |
chr4_-_129467430 | 12.65 |
ENSMUST00000102596.8
|
Lck
|
lymphocyte protein tyrosine kinase |
chr15_-_9529898 | 12.27 |
ENSMUST00000228782.2
ENSMUST00000003981.6 |
Il7r
|
interleukin 7 receptor |
chr2_+_164790139 | 12.17 |
ENSMUST00000017881.3
|
Mmp9
|
matrix metallopeptidase 9 |
chr19_-_10807409 | 12.11 |
ENSMUST00000080292.12
|
Cd6
|
CD6 antigen |
chr19_-_10807285 | 11.84 |
ENSMUST00000039043.15
|
Cd6
|
CD6 antigen |
chr18_-_35782412 | 11.00 |
ENSMUST00000025211.6
|
Mzb1
|
marginal zone B and B1 cell-specific protein 1 |
chr6_-_136918495 | 10.94 |
ENSMUST00000111892.8
|
Arhgdib
|
Rho, GDP dissociation inhibitor (GDI) beta |
chr11_-_46280281 | 10.87 |
ENSMUST00000101306.4
|
Itk
|
IL2 inducible T cell kinase |
chr6_+_41118120 | 10.68 |
ENSMUST00000103273.3
|
Trbv15
|
T cell receptor beta, variable 15 |
chr15_-_97742134 | 10.48 |
ENSMUST00000119670.8
ENSMUST00000116409.9 |
Hdac7
|
histone deacetylase 7 |
chr19_+_4264292 | 10.14 |
ENSMUST00000046506.7
|
Clcf1
|
cardiotrophin-like cytokine factor 1 |
chr11_+_95733109 | 10.12 |
ENSMUST00000107714.9
ENSMUST00000107711.8 |
Gngt2
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
chrX_+_158480304 | 10.11 |
ENSMUST00000123433.8
|
Sh3kbp1
|
SH3-domain kinase binding protein 1 |
chrX_+_106299484 | 10.07 |
ENSMUST00000101294.9
ENSMUST00000118820.8 ENSMUST00000120971.8 |
Gpr174
|
G protein-coupled receptor 174 |
chr5_-_107873883 | 9.84 |
ENSMUST00000159263.3
|
Gfi1
|
growth factor independent 1 transcription repressor |
chr3_-_96721829 | 9.70 |
ENSMUST00000047702.8
|
Cd160
|
CD160 antigen |
chr7_-_126736979 | 9.49 |
ENSMUST00000049931.6
|
Spn
|
sialophorin |
chr12_-_112824506 | 9.48 |
ENSMUST00000021729.9
|
Gpr132
|
G protein-coupled receptor 132 |
chr4_+_134847949 | 9.42 |
ENSMUST00000056977.14
|
Runx3
|
runt related transcription factor 3 |
chr15_-_97742045 | 9.41 |
ENSMUST00000120683.8
|
Hdac7
|
histone deacetylase 7 |
chr14_+_71011744 | 9.37 |
ENSMUST00000022698.8
|
Dok2
|
docking protein 2 |
chr11_-_79421397 | 9.34 |
ENSMUST00000103236.4
ENSMUST00000170799.8 ENSMUST00000170422.4 |
Evi2a
Evi2
|
ecotropic viral integration site 2a ecotropic viral integration site 2 |
chr12_+_85733415 | 9.06 |
ENSMUST00000040536.6
|
Batf
|
basic leucine zipper transcription factor, ATF-like |
chr6_-_136918671 | 8.81 |
ENSMUST00000032344.12
|
Arhgdib
|
Rho, GDP dissociation inhibitor (GDI) beta |
chr19_-_10807220 | 8.66 |
ENSMUST00000174176.3
|
Cd6
|
CD6 antigen |
chr6_-_69521891 | 8.37 |
ENSMUST00000103356.4
|
Igkv4-57-1
|
immunoglobulin kappa variable 4-57-1 |
chr17_+_47906985 | 7.93 |
ENSMUST00000182539.8
|
Ccnd3
|
cyclin D3 |
chr2_+_172235702 | 7.52 |
ENSMUST00000099061.9
ENSMUST00000103073.9 |
Cass4
|
Cas scaffolding protein family member 4 |
chr17_-_45125537 | 7.48 |
ENSMUST00000113571.10
|
Runx2
|
runt related transcription factor 2 |
chr17_+_31427023 | 7.39 |
ENSMUST00000173776.2
ENSMUST00000048656.15 |
Ubash3a
|
ubiquitin associated and SH3 domain containing, A |
chr4_-_46404224 | 7.38 |
ENSMUST00000107764.9
|
Hemgn
|
hemogen |
chr17_+_29712008 | 7.32 |
ENSMUST00000234665.2
|
Pim1
|
proviral integration site 1 |
chr1_-_164763091 | 7.32 |
ENSMUST00000027860.8
|
Xcl1
|
chemokine (C motif) ligand 1 |
chr15_-_103163860 | 7.23 |
ENSMUST00000075192.13
|
Nfe2
|
nuclear factor, erythroid derived 2 |
chr18_-_62313019 | 7.17 |
ENSMUST00000053640.5
|
Adrb2
|
adrenergic receptor, beta 2 |
chr5_-_92475927 | 7.00 |
ENSMUST00000113093.5
|
Cxcl9
|
chemokine (C-X-C motif) ligand 9 |
chr5_-_72893941 | 6.83 |
ENSMUST00000169534.6
|
Txk
|
TXK tyrosine kinase |
chr2_-_73316053 | 6.81 |
ENSMUST00000102680.8
|
Wipf1
|
WAS/WASL interacting protein family, member 1 |
chrX_+_7445806 | 6.74 |
ENSMUST00000234363.2
ENSMUST00000235116.2 ENSMUST00000115739.9 ENSMUST00000234574.2 ENSMUST00000115740.9 |
Foxp3
|
forkhead box P3 |
chr15_+_97259060 | 6.57 |
ENSMUST00000228521.2
ENSMUST00000226495.2 |
Pced1b
|
PC-esterase domain containing 1B |
chr2_+_172235820 | 6.44 |
ENSMUST00000109136.3
ENSMUST00000228775.2 |
Cass4
|
Cas scaffolding protein family member 4 |
chr1_+_171216480 | 6.15 |
ENSMUST00000056449.9
|
Arhgap30
|
Rho GTPase activating protein 30 |
chr11_+_6511133 | 6.13 |
ENSMUST00000160633.8
ENSMUST00000109721.3 |
Ccm2
|
cerebral cavernous malformation 2 |
chr14_-_56499690 | 6.08 |
ENSMUST00000015581.6
|
Gzmb
|
granzyme B |
chr7_-_24831892 | 6.05 |
ENSMUST00000108418.11
ENSMUST00000175774.9 ENSMUST00000108415.10 ENSMUST00000098679.10 ENSMUST00000108417.10 ENSMUST00000108416.10 ENSMUST00000108413.8 ENSMUST00000176408.8 |
Pou2f2
|
POU domain, class 2, transcription factor 2 |
chr2_-_27974889 | 5.81 |
ENSMUST00000028179.15
ENSMUST00000117486.8 ENSMUST00000135472.2 |
Fcnb
|
ficolin B |
chr7_+_126184108 | 5.62 |
ENSMUST00000039522.8
|
Apobr
|
apolipoprotein B receptor |
chr2_+_163662752 | 5.47 |
ENSMUST00000029188.8
|
Ccn5
|
cellular communication network factor 5 |
chr12_-_114878652 | 5.09 |
ENSMUST00000103515.2
|
Ighv1-39
|
immunoglobulin heavy variable 1-39 |
chr14_+_53994813 | 4.95 |
ENSMUST00000180380.3
|
Trav13-4-dv7
|
T cell receptor alpha variable 13-4-DV7 |
chr7_+_30264835 | 4.89 |
ENSMUST00000043850.14
|
Igflr1
|
IGF-like family receptor 1 |
chrX_+_158410528 | 4.86 |
ENSMUST00000073094.10
|
Sh3kbp1
|
SH3-domain kinase binding protein 1 |
chr2_+_32611067 | 4.72 |
ENSMUST00000074248.11
|
Sh2d3c
|
SH2 domain containing 3C |
chr17_-_37269330 | 4.65 |
ENSMUST00000113669.9
|
Polr1h
|
RNA polymerase I subunit H |
chr13_+_76727787 | 4.63 |
ENSMUST00000126960.8
ENSMUST00000109583.9 |
Mctp1
|
multiple C2 domains, transmembrane 1 |
chr1_+_36346824 | 4.57 |
ENSMUST00000142319.8
ENSMUST00000097778.9 ENSMUST00000115031.8 ENSMUST00000115032.8 ENSMUST00000137906.2 ENSMUST00000115029.2 |
Arid5a
|
AT rich interactive domain 5A (MRF1-like) |
chr17_-_37269425 | 4.56 |
ENSMUST00000172518.8
|
Polr1h
|
RNA polymerase I subunit H |
chr1_+_40554513 | 4.54 |
ENSMUST00000027237.12
|
Il18rap
|
interleukin 18 receptor accessory protein |
chr16_-_95387444 | 4.45 |
ENSMUST00000233269.2
|
Erg
|
ETS transcription factor |
chr7_-_43182595 | 4.37 |
ENSMUST00000205503.2
|
Cd33
|
CD33 antigen |
chr11_+_87684299 | 4.34 |
ENSMUST00000020779.11
|
Mpo
|
myeloperoxidase |
chr11_-_95733235 | 4.26 |
ENSMUST00000059026.10
|
Abi3
|
ABI family member 3 |
chr17_-_37269153 | 4.23 |
ENSMUST00000172823.2
|
Polr1h
|
RNA polymerase I subunit H |
chr17_+_26882171 | 4.19 |
ENSMUST00000236346.2
|
Atp6v0e
|
ATPase, H+ transporting, lysosomal V0 subunit E |
chr19_+_4264470 | 4.17 |
ENSMUST00000237171.2
|
Gm45928
|
predicted gene, 45928 |
chr4_+_102848981 | 4.14 |
ENSMUST00000140654.9
|
Dynlt5
|
dynein light chain Tctex-type 5 |
chr11_+_75422516 | 4.02 |
ENSMUST00000149727.8
ENSMUST00000108433.8 ENSMUST00000042561.14 ENSMUST00000143035.8 |
Slc43a2
|
solute carrier family 43, member 2 |
chr14_+_52921421 | 4.01 |
ENSMUST00000200127.2
|
Trav7d-2
|
T cell receptor alpha variable 7D-2 |
chr14_+_54183465 | 3.83 |
ENSMUST00000197130.5
ENSMUST00000103677.3 |
Trdv2-1
|
T cell receptor delta variable 2-1 |
chr9_-_56151334 | 3.61 |
ENSMUST00000188142.7
|
Peak1
|
pseudopodium-enriched atypical kinase 1 |
chr17_+_44445659 | 3.44 |
ENSMUST00000239215.2
|
Clic5
|
chloride intracellular channel 5 |
chrX_-_12026594 | 3.44 |
ENSMUST00000043441.13
|
Bcor
|
BCL6 interacting corepressor |
chr19_+_4264437 | 3.43 |
ENSMUST00000235355.2
|
Clcf1
|
cardiotrophin-like cytokine factor 1 |
chr12_-_115706126 | 3.42 |
ENSMUST00000166645.2
ENSMUST00000196690.2 |
Ighv1-71
|
immunoglobulin heavy variable 1-71 |
chr15_+_80595486 | 3.37 |
ENSMUST00000067689.9
|
Tnrc6b
|
trinucleotide repeat containing 6b |
chr11_+_75422925 | 3.33 |
ENSMUST00000169547.9
|
Slc43a2
|
solute carrier family 43, member 2 |
chr11_-_83540175 | 3.24 |
ENSMUST00000001008.6
|
Ccl3
|
chemokine (C-C motif) ligand 3 |
chr19_-_45619559 | 3.21 |
ENSMUST00000160718.9
|
Fbxw4
|
F-box and WD-40 domain protein 4 |
chr1_-_161616031 | 3.12 |
ENSMUST00000000834.4
|
Fasl
|
Fas ligand (TNF superfamily, member 6) |
chr9_-_107648144 | 3.11 |
ENSMUST00000183248.3
ENSMUST00000182022.8 ENSMUST00000035199.13 ENSMUST00000182659.8 |
Rbm5
|
RNA binding motif protein 5 |
chr9_-_103569984 | 3.02 |
ENSMUST00000049452.15
|
Tmem108
|
transmembrane protein 108 |
chr12_-_115410489 | 2.98 |
ENSMUST00000194581.2
|
Ighv1-62-2
|
immunoglobulin heavy variable 1-62-2 |
chr8_+_84852609 | 2.91 |
ENSMUST00000093380.5
|
Podnl1
|
podocan-like 1 |
chr16_-_16681839 | 2.89 |
ENSMUST00000100136.4
|
Igll1
|
immunoglobulin lambda-like polypeptide 1 |
chr4_-_70328659 | 2.89 |
ENSMUST00000144099.8
|
Cdk5rap2
|
CDK5 regulatory subunit associated protein 2 |
chr14_-_66518399 | 2.86 |
ENSMUST00000111121.2
ENSMUST00000022622.14 ENSMUST00000089250.9 |
Ptk2b
|
PTK2 protein tyrosine kinase 2 beta |
chr15_-_98505508 | 2.85 |
ENSMUST00000096224.6
|
Adcy6
|
adenylate cyclase 6 |
chr10_+_118276949 | 2.83 |
ENSMUST00000068592.5
|
Ifng
|
interferon gamma |
chr4_-_133600308 | 2.79 |
ENSMUST00000137486.3
|
Rps6ka1
|
ribosomal protein S6 kinase polypeptide 1 |
chr11_-_115426618 | 2.75 |
ENSMUST00000121185.8
ENSMUST00000117589.8 |
Sumo2
|
small ubiquitin-like modifier 2 |
chrX_-_100777806 | 2.65 |
ENSMUST00000056614.7
|
Cxcr3
|
chemokine (C-X-C motif) receptor 3 |
chr11_+_75422953 | 2.64 |
ENSMUST00000127226.3
|
Slc43a2
|
solute carrier family 43, member 2 |
chr11_-_100986192 | 2.64 |
ENSMUST00000019447.15
|
Psmc3ip
|
proteasome (prosome, macropain) 26S subunit, ATPase 3, interacting protein |
chr3_-_86049988 | 2.59 |
ENSMUST00000029722.7
|
Rps3a1
|
ribosomal protein S3A1 |
chr12_-_34578842 | 2.58 |
ENSMUST00000110819.4
|
Hdac9
|
histone deacetylase 9 |
chr14_+_53872276 | 2.54 |
ENSMUST00000103658.4
|
Trav13-2
|
T cell receptor alpha variable 13-2 |
chr9_+_113641615 | 2.54 |
ENSMUST00000111838.10
ENSMUST00000166734.10 ENSMUST00000214522.2 ENSMUST00000163895.3 |
Clasp2
|
CLIP associating protein 2 |
chr7_+_126184141 | 2.40 |
ENSMUST00000137646.8
|
Apobr
|
apolipoprotein B receptor |
chr7_-_43182504 | 2.40 |
ENSMUST00000004728.12
|
Cd33
|
CD33 antigen |
chr7_-_126183392 | 2.32 |
ENSMUST00000128970.8
ENSMUST00000116269.9 |
Cln3
|
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
chr12_-_115964081 | 2.26 |
ENSMUST00000103552.2
|
Ighv1-85
|
immunoglobulin heavy variable 1-85 |
chr15_-_102630589 | 2.24 |
ENSMUST00000023818.11
|
Calcoco1
|
calcium binding and coiled coil domain 1 |
chr4_+_132903646 | 2.23 |
ENSMUST00000105912.2
|
Wasf2
|
WASP family, member 2 |
chr11_-_24025054 | 2.19 |
ENSMUST00000068360.2
|
A830031A19Rik
|
RIKEN cDNA A830031A19 gene |
chr10_-_35587888 | 2.17 |
ENSMUST00000080898.4
|
Amd2
|
S-adenosylmethionine decarboxylase 2 |
chr6_-_69477770 | 2.16 |
ENSMUST00000197448.2
|
Igkv4-58
|
immunoglobulin kappa variable 4-58 |
chr2_-_73316809 | 2.11 |
ENSMUST00000141264.8
|
Wipf1
|
WAS/WASL interacting protein family, member 1 |
chr13_+_76727799 | 2.11 |
ENSMUST00000109589.3
|
Mctp1
|
multiple C2 domains, transmembrane 1 |
chr15_-_102630496 | 2.08 |
ENSMUST00000171838.2
|
Calcoco1
|
calcium binding and coiled coil domain 1 |
chr16_+_91188609 | 2.05 |
ENSMUST00000160764.2
|
Gm21970
|
predicted gene 21970 |
chr19_+_5618029 | 1.92 |
ENSMUST00000235575.2
ENSMUST00000235542.2 |
Ap5b1
|
adaptor-related protein complex 5, beta 1 subunit |
chr11_-_108234743 | 1.91 |
ENSMUST00000059595.11
|
Prkca
|
protein kinase C, alpha |
chr2_-_25911691 | 1.81 |
ENSMUST00000036509.14
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr11_-_53525520 | 1.77 |
ENSMUST00000020650.2
|
Il13
|
interleukin 13 |
chr10_-_80382611 | 1.77 |
ENSMUST00000183233.9
ENSMUST00000182604.8 |
Rexo1
|
REX1, RNA exonuclease 1 |
chr8_-_11058458 | 1.76 |
ENSMUST00000040514.8
|
Irs2
|
insulin receptor substrate 2 |
chr1_-_161615927 | 1.70 |
ENSMUST00000193648.2
|
Fasl
|
Fas ligand (TNF superfamily, member 6) |
chr17_+_47604995 | 1.68 |
ENSMUST00000190020.4
|
Trerf1
|
transcriptional regulating factor 1 |
chr6_-_99073156 | 1.66 |
ENSMUST00000175886.8
|
Foxp1
|
forkhead box P1 |
chr11_-_54140462 | 1.66 |
ENSMUST00000019060.6
|
Csf2
|
colony stimulating factor 2 (granulocyte-macrophage) |
chr10_-_5144699 | 1.62 |
ENSMUST00000215467.2
|
Syne1
|
spectrin repeat containing, nuclear envelope 1 |
chr3_-_88286006 | 1.62 |
ENSMUST00000098956.3
|
Bglap2
|
bone gamma-carboxyglutamate protein 2 |
chr7_-_126183716 | 1.58 |
ENSMUST00000150311.8
|
Cln3
|
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
chr11_-_72106418 | 1.57 |
ENSMUST00000021157.9
|
Med31
|
mediator complex subunit 31 |
chr17_+_33857030 | 1.55 |
ENSMUST00000052079.8
|
Pram1
|
PML-RAR alpha-regulated adaptor molecule 1 |
chr2_+_164302863 | 1.53 |
ENSMUST00000072452.11
|
Sys1
|
SYS1 Golgi-localized integral membrane protein homolog (S. cerevisiae) |
chr5_+_24618380 | 1.53 |
ENSMUST00000049346.10
|
Asic3
|
acid-sensing (proton-gated) ion channel 3 |
chr9_-_44144772 | 1.47 |
ENSMUST00000205755.2
|
Cbl
|
Casitas B-lineage lymphoma |
chr5_+_139392142 | 1.45 |
ENSMUST00000052176.9
|
C130050O18Rik
|
RIKEN cDNA C130050O18 gene |
chr5_-_75205358 | 1.45 |
ENSMUST00000075452.7
|
Chic2
|
cysteine-rich hydrophobic domain 2 |
chr9_+_7272514 | 1.37 |
ENSMUST00000015394.10
|
Mmp13
|
matrix metallopeptidase 13 |
chr1_-_14380418 | 1.36 |
ENSMUST00000027066.13
ENSMUST00000168081.9 |
Eya1
|
EYA transcriptional coactivator and phosphatase 1 |
chr2_-_25911544 | 1.35 |
ENSMUST00000136750.3
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr17_-_45125468 | 1.32 |
ENSMUST00000159943.8
ENSMUST00000160673.8 |
Runx2
|
runt related transcription factor 2 |
chr16_-_58539433 | 1.22 |
ENSMUST00000089318.5
|
Gpr15
|
G protein-coupled receptor 15 |
chr11_-_99511257 | 1.20 |
ENSMUST00000073853.3
|
Gm11562
|
predicted gene 11562 |
chr1_-_192946359 | 1.19 |
ENSMUST00000161737.8
|
Hsd11b1
|
hydroxysteroid 11-beta dehydrogenase 1 |
chr6_+_11907808 | 1.17 |
ENSMUST00000155037.4
|
Phf14
|
PHD finger protein 14 |
chr10_-_14593935 | 1.16 |
ENSMUST00000020016.5
|
Gje1
|
gap junction protein, epsilon 1 |
chr19_+_5618096 | 1.05 |
ENSMUST00000096318.4
|
Ap5b1
|
adaptor-related protein complex 5, beta 1 subunit |
chr4_-_6990774 | 1.04 |
ENSMUST00000039987.4
|
Tox
|
thymocyte selection-associated high mobility group box |
chrX_-_20816841 | 1.02 |
ENSMUST00000009550.14
|
Elk1
|
ELK1, member of ETS oncogene family |
chr4_-_137137088 | 0.99 |
ENSMUST00000024200.7
|
Cela3a
|
chymotrypsin-like elastase family, member 3A |
chr11_+_116324913 | 0.93 |
ENSMUST00000057676.7
|
Ubald2
|
UBA-like domain containing 2 |
chr16_+_25620652 | 0.91 |
ENSMUST00000115304.8
ENSMUST00000115305.2 ENSMUST00000040231.13 ENSMUST00000115306.8 |
Trp63
|
transformation related protein 63 |
chr3_+_102965601 | 0.88 |
ENSMUST00000029445.13
ENSMUST00000200069.5 |
Nras
|
neuroblastoma ras oncogene |
chr17_+_75485791 | 0.86 |
ENSMUST00000135447.8
ENSMUST00000112516.8 |
Ltbp1
|
latent transforming growth factor beta binding protein 1 |
chr2_+_153780138 | 0.73 |
ENSMUST00000109757.8
ENSMUST00000154281.3 |
Bpifb4
|
BPI fold containing family B, member 4 |
chr11_+_11414256 | 0.61 |
ENSMUST00000020410.11
|
Spata48
|
spermatogenesis associated 48 |
chr16_-_94046925 | 0.56 |
ENSMUST00000228910.2
|
Hlcs
|
holocarboxylase synthetase (biotin- [propriony-Coenzyme A-carboxylase (ATP-hydrolysing)] ligase) |
chrX_+_162691978 | 0.51 |
ENSMUST00000069041.15
|
Ap1s2
|
adaptor-related protein complex 1, sigma 2 subunit |
chr11_-_110058899 | 0.50 |
ENSMUST00000044850.4
|
Abca9
|
ATP-binding cassette, sub-family A (ABC1), member 9 |
chr12_-_115276219 | 0.48 |
ENSMUST00000103529.4
|
Ighv1-58
|
immunoglobulin heavy variable 1-58 |
chr12_+_114594300 | 0.48 |
ENSMUST00000095364.3
|
ENSMUSG00000090765.2
|
|
chr2_-_89774457 | 0.43 |
ENSMUST00000090695.3
|
Olfr1259
|
olfactory receptor 1259 |
chr10_-_12490424 | 0.39 |
ENSMUST00000217994.2
|
Utrn
|
utrophin |
chr5_+_87955941 | 0.38 |
ENSMUST00000072539.12
ENSMUST00000113279.8 ENSMUST00000101057.8 ENSMUST00000197301.2 |
Csn1s2b
|
casein alpha s2-like B |
chr6_+_136495784 | 0.35 |
ENSMUST00000032335.13
ENSMUST00000185724.7 |
Atf7ip
|
activating transcription factor 7 interacting protein |
chr12_+_73984427 | 0.31 |
ENSMUST00000221833.2
|
Snapc1l
|
small nuclear RNA activating complex, polypeptide 1 like |
chr7_-_45083688 | 0.28 |
ENSMUST00000210439.2
|
Ruvbl2
|
RuvB-like protein 2 |
chr11_-_100098333 | 0.27 |
ENSMUST00000007272.8
|
Krt14
|
keratin 14 |
chr17_-_34962823 | 0.26 |
ENSMUST00000069507.9
|
C4b
|
complement component 4B (Chido blood group) |
chr2_+_125876566 | 0.25 |
ENSMUST00000064794.14
|
Fgf7
|
fibroblast growth factor 7 |
chr11_-_3321307 | 0.21 |
ENSMUST00000101640.10
ENSMUST00000101642.10 |
Limk2
|
LIM motif-containing protein kinase 2 |
chr8_-_55340024 | 0.17 |
ENSMUST00000176866.8
|
Wdr17
|
WD repeat domain 17 |
chr6_+_21985902 | 0.17 |
ENSMUST00000115383.9
|
Cped1
|
cadherin-like and PC-esterase domain containing 1 |
chr17_+_75485906 | 0.17 |
ENSMUST00000112514.2
|
Ltbp1
|
latent transforming growth factor beta binding protein 1 |
chr16_+_43330630 | 0.15 |
ENSMUST00000114695.3
|
Zbtb20
|
zinc finger and BTB domain containing 20 |
chr12_-_115567853 | 0.15 |
ENSMUST00000103538.3
ENSMUST00000198646.2 |
Ighv1-67
|
immunoglobulin heavy variable V1-67 |
chr11_-_100305654 | 0.12 |
ENSMUST00000066489.13
|
P3h4
|
prolyl 3-hydroxylase family member 4 (non-enzymatic) |
chr10_+_127575407 | 0.11 |
ENSMUST00000054287.9
|
Zbtb39
|
zinc finger and BTB domain containing 39 |
chr5_-_138153956 | 0.09 |
ENSMUST00000132318.2
ENSMUST00000049393.15 |
Zfp113
|
zinc finger protein 113 |
chr14_-_56299764 | 0.02 |
ENSMUST00000043249.10
|
Mcpt4
|
mast cell protease 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.9 | 26.8 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
8.7 | 43.5 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
4.9 | 14.7 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
4.7 | 14.0 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
4.1 | 12.2 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
3.6 | 14.4 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
3.2 | 9.5 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
3.1 | 12.3 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
3.1 | 12.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
2.5 | 9.8 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
2.2 | 6.7 | GO:0002849 | positive regulation of tolerance induction dependent upon immune response(GO:0002654) regulation of peripheral tolerance induction(GO:0002658) positive regulation of peripheral tolerance induction(GO:0002660) regulation of peripheral T cell tolerance induction(GO:0002849) positive regulation of peripheral T cell tolerance induction(GO:0002851) |
2.2 | 44.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
2.2 | 19.8 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
2.2 | 4.4 | GO:2000556 | regulation of T-helper 1 cell cytokine production(GO:2000554) positive regulation of T-helper 1 cell cytokine production(GO:2000556) |
2.0 | 6.0 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
1.8 | 18.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
1.8 | 7.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.5 | 32.6 | GO:0001771 | immunological synapse formation(GO:0001771) |
1.4 | 2.9 | GO:2000538 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
1.4 | 22.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
1.3 | 13.1 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
1.3 | 19.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
1.2 | 6.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.2 | 4.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.2 | 5.8 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.0 | 12.6 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
1.0 | 2.9 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.9 | 0.9 | GO:0060197 | cloacal septation(GO:0060197) |
0.9 | 3.4 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.8 | 7.3 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.8 | 3.9 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.7 | 4.5 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.7 | 8.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.7 | 10.7 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.7 | 2.0 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
0.6 | 6.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.6 | 1.8 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.6 | 1.8 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.6 | 10.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.5 | 7.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.5 | 7.2 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.5 | 1.9 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.5 | 48.4 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.4 | 3.0 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.4 | 1.2 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.4 | 9.6 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.4 | 2.9 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.3 | 2.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 1.4 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.3 | 7.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 8.9 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.3 | 9.4 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.3 | 3.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.3 | 3.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.3 | 3.4 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.3 | 1.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.3 | 2.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.2 | 1.2 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.2 | 1.6 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 1.8 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.2 | 20.6 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.2 | 1.7 | GO:0072619 | interleukin-21 production(GO:0032625) T follicular helper cell differentiation(GO:0061470) interleukin-21 secretion(GO:0072619) |
0.2 | 1.5 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.2 | 9.2 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.2 | 2.4 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.6 | GO:0071110 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
0.1 | 14.3 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 9.7 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 4.2 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.1 | 13.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 2.7 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 2.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 3.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 3.7 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.3 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.1 | 14.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 1.2 | GO:0072678 | T cell migration(GO:0072678) |
0.1 | 0.4 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.1 | 8.0 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 6.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 12.1 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 1.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 2.6 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 1.6 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 3.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 7.1 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.0 | 1.0 | GO:0010714 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.0 | 2.6 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 3.1 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 2.6 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.0 | 1.5 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 1.6 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.0 | 8.4 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.0 | 1.2 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.5 | GO:0060612 | adipose tissue development(GO:0060612) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 32.6 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
2.7 | 13.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
1.2 | 6.1 | GO:0044194 | cytolytic granule(GO:0044194) |
1.2 | 13.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.8 | 2.5 | GO:1904511 | cortical microtubule plus-end(GO:1903754) cytoplasmic microtubule plus-end(GO:1904511) |
0.7 | 11.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.6 | 9.5 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 15.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 99.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.4 | 5.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.4 | 8.0 | GO:0042627 | chylomicron(GO:0042627) |
0.3 | 1.0 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.3 | 16.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.3 | 4.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 13.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 23.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 1.6 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 96.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 2.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 15.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.2 | 7.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 2.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 1.6 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 2.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 1.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 3.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 9.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 7.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 12.5 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 18.6 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 1.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 3.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 3.4 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 3.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 10.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 20.3 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 23.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 6.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 1.2 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 2.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 3.9 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.6 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 1.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 1.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 47.7 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 1.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 2.7 | GO:0016605 | PML body(GO:0016605) |
0.0 | 2.8 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 15.1 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.5 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.0 | 5.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 1.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 3.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 2.8 | GO:0005819 | spindle(GO:0005819) |
0.0 | 11.7 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.3 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
3.6 | 32.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
2.5 | 12.6 | GO:0042610 | CD8 receptor binding(GO:0042610) |
2.2 | 19.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.8 | 7.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.3 | 26.1 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
1.2 | 7.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.1 | 13.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
1.1 | 99.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.0 | 8.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.9 | 14.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.9 | 22.2 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.8 | 26.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.6 | 1.9 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.6 | 7.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 5.8 | GO:0033691 | sialic acid binding(GO:0033691) |
0.4 | 6.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 2.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.4 | 10.1 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.4 | 1.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.4 | 13.1 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.4 | 2.6 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.4 | 10.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.4 | 13.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.3 | 4.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.3 | 10.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.3 | 2.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 14.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 11.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 1.0 | GO:0050436 | microfibril binding(GO:0050436) |
0.3 | 1.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 1.8 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 1.6 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 23.5 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.2 | 2.7 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 4.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 4.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 2.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 4.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 10.0 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 8.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.6 | GO:0018271 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
0.1 | 7.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 4.2 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.4 | GO:0035375 | zymogen binding(GO:0035375) |
0.1 | 21.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 12.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 13.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 13.1 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 20.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 14.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.6 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 2.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 7.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 2.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 1.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.3 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.0 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 2.0 | GO:0004601 | peroxidase activity(GO:0004601) |
0.0 | 9.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 1.8 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 5.8 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 1.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 7.6 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 32.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.2 | 100.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.6 | 49.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.5 | 2.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 6.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 1.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.4 | 22.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 2.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.4 | 14.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 14.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 9.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 7.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 20.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.3 | 14.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 25.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 12.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 15.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 6.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 8.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 7.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 13.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 19.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 1.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 2.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 18.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 18.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 2.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 13.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 6.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 3.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 45.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
2.8 | 83.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.4 | 16.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.5 | 12.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 10.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 13.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 13.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.4 | 16.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.4 | 13.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.4 | 20.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 22.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 8.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 9.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 10.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 2.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 3.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 9.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 7.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 8.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 2.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 7.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 1.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.8 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 6.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 24.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 3.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 20.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 3.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 7.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 2.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 1.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 1.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 3.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 1.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |